Arcutis Biotherapeutics Inc.(ARQT)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARQT Arcutis Biotherapeutics Inc.

盘前交易 07-01 06:15:23 EDT

9.30

-0.12

-1.27%

最高9.59	最低9.01	成交量673.48万
今开9.51	昨收9.42	日振幅6.16%
总市值10.77亿	流通市值8.30亿	总股本1.16亿
成交额6,247万	换手率7.55%	流通股本8,926万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARQT","market":"US","secType":"STK","nameCN":"Arcutis Biotherapeutics Inc.","latestPrice":9.3,"timestamp":1719604800000,"preClose":9.42,"halted":0,"volume":6734824,"delay":0,"floatShares":89255594,"shares":115764164,"eps":-2.658771,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.12,"latestTime":"07-01 06:15:23 EDT","open":9.51,"high":9.59,"low":9.01,"amount":62473028.868056,"amplitude":0.061571,"askPrice":10.25,"askSize":100,"bidPrice":9.31,"bidSize":107,"shortable":3,"etf":0,"ttmEps":-2.658771,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1719840600000},"adr":0,"listingDate":1580446800000,"adjPreClose":9.3,"postHourTrading":{"tag":"盘后","latestPrice":9.49,"preClose":9.3,"latestTime":"19:23 EDT","volume":1674606,"amount":15574267.302366,"timestamp":1719616980102},"volumeRatio":1.858570538435821,"impliedVol":1.2042,"impliedVolPercentile":0.564},"requestUrl":"/m/hq/s/ARQT","defaultTab":"news","newsList":[{"id":"2446311818","title":"Arcutis Biotherapeutics, Inc.盘中异动 下午盘急速下挫5.00%报9.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446311818","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446311818?lang=zh_cn&edition=full","pubTime":"2024-06-27 01:32","pubTimestamp":1719423151,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日01时32分，Arcutis Biotherapeutics, Inc.股票出现异动，股价大幅跳水5.00%。截至发稿，该股报9.12美元/股，成交量112.892万股，换手率0.98%，振幅7.50%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.45%。其相关个股中，Anew Medical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为721.00%、157.97%、115.72%，振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为112.12%、51.85%、50.25%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062701323196817208&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062701323196817208&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT","BK4139"],"gpt_icon":0},{"id":"2446382207","title":"Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446382207","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446382207?lang=zh_cn&edition=full","pubTime":"2024-06-26 01:55","pubTimestamp":1719338153,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日01时55分，Arcutis Biotherapeutics, Inc.股票出现波动，股价快速拉升5.12%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Cns Pharmaceuticals, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为973.43%、235.46%、178.85%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.，振幅分别为272.73%、77.13%、47.00%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626015553af8f2429&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626015553af8f2429&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2445728810","title":"Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.30%报8.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445728810","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445728810?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:40","pubTimestamp":1719236456,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时40分，Arcutis Biotherapeutics, Inc.股票出现波动，股价大幅拉升5.30%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Revelation Biosciences, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Revelation Biosciences, Inc.、Geovax Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为941.50%、54.28%、47.43%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Geovax Labs Inc C/Wts 29/09/2025、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为68.00%、51.43%、50.87%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214056968163ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214056968163ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2444198702","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘快速跳水5.33%报8.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444198702","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444198702?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:08","pubTimestamp":1718633336,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时08分，Arcutis Biotherapeutics, Inc.股票出现异动，股价大幅下挫5.33%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Xtl生物制药涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为3867.27%、741.13%、116.93%，振幅较大的相关个股有Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Sellas Life Sciences Group, Inc.，振幅分别为93.85%、42.41%、29.99%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617220856af8de402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617220856af8de402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2443791736","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘快速下跌5.03%报8.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443791736","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443791736?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:25","pubTimestamp":1718375145,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时25分，Arcutis Biotherapeutics, Inc.股票出现异动，股价大幅下跌5.03%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Cns Pharmaceuticals, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Longeveron Inc.涨幅较大，Longeveron Inc.、Bio-Path Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为743.20%、202.87%、183.03%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Kyverna Therapeutics, Inc.，振幅分别为88.40%、57.51%、39.40%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614222545941eeae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614222545941eeae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT","BK4139","LGVN"],"gpt_icon":0},{"id":"2443568425","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘股价大涨5.00%报8.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443568425","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443568425?lang=zh_cn&edition=full","pubTime":"2024-06-13 22:18","pubTimestamp":1718288332,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日22时18分，Arcutis Biotherapeutics, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报8.51美元/股，成交量35.0197万股，换手率0.30%，振幅6.17%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Clene Inc C/Wts 30/12/2025 、Longeveron Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Biorestorative Therapies, Inc.、Longeveron Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为1035.49%、953.36%、109.57%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Longeveron Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为74.62%、57.45%、49.23%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406132218529681406e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406132218529681406e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT","BK4139","LGVN"],"gpt_icon":0},{"id":"2442956554","title":"Arcutis Biotherapeutics, Inc.盘中异动 大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442956554","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442956554?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199083,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Arcutis Biotherapeutics, Inc.股票出现波动，股价急速上涨5.01%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Avidity Biosciences, Inc.、Passage Bio, Inc.、Molecular Partners Ag涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为36.27%、18.90%、3.57%，振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Akari Therapeutics Plc，振幅分别为21.10%、20.93%、8.28%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213123941ee09c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213123941ee09c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2441094375","title":"Arcutis Biotherapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441094375","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441094375?lang=zh_cn&edition=full","pubTime":"2024-06-08 02:01","pubTimestamp":1717783276,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日02时01分，Arcutis Biotherapeutics, Inc.股票出现波动，股价急速下跌5.00%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cingulate Inc C/Wts 10/12/2026 、In8Bio, Inc.涨幅较大，Biocardia, Inc.、Scinai Immunotherapeutics Ltd、Virax Biolabs Group Limited较为活跃，换手率分别为355.50%、113.95%、73.16%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为178.69%、99.48%、65.15%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608020117941ed5a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608020117941ed5a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2441723989","title":"Arcutis Biotherapeutics, Inc.盘中异动 大幅跳水5.03%报7.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441723989","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441723989?lang=zh_cn&edition=full","pubTime":"2024-06-07 01:44","pubTimestamp":1717695867,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日01时44分，Arcutis Biotherapeutics, Inc.股票出现异动，股价大幅跳水5.03%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Virax Biolabs Group Limited、Fibrobiologics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为3133.24%、84.46%、49.79%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virax Biolabs Group Limited、Fibrobiologics, Inc.，振幅分别为129.76%、86.92%、70.00%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060701442796812a76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060701442796812a76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT","BK4139"],"gpt_icon":0},{"id":"2440413179","title":"Arcutis Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440413179","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440413179?lang=zh_cn&edition=full","pubTime":"2024-06-01 02:51","pubTimestamp":1717181471,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日02时51分，Arcutis Biotherapeutics, Inc.股票出现波动，股价快速下挫5.25%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。消息层面，截至02时51分，《Form 144 | Arcutis Biotherapeutics高管拟出售5万股股份，价值约43.54万美元》资讯为影响Arcutis Biotherapeutics, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间5月29日披露的文件，$Arcutis Biotherapeutics $高管Burnett Patrick拟于5月29日出售5万股普通股股份，总市值约43.54万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601025111af8b6beb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601025111af8b6beb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT","BK4139"],"gpt_icon":0},{"id":"2439652041","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘大幅跳水5.01%报8.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439652041","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439652041?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:52","pubTimestamp":1716990720,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日21时52分，Arcutis Biotherapeutics, Inc.股票出现异动，股价大幅跳水5.01%。截至发稿，该股报8.44美元/股，成交量20.8993万股，换手率0.18%，振幅3.83%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Celularity Inc C/Wts 16/07/2026 、Mustang Bio, Inc.涨幅较大，Mustang Bio, Inc.、Scorpius Holdings, Inc.、Kintara Therapeutics, Inc.较为活跃，换手率分别为116.70%、80.00%、11.96%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Gyre Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为97.00%、29.46%、27.73%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529215200af8aee30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529215200af8aee30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2436198205","title":"Arcutis Biotherapeutics, Inc.2024财年第一财季实现净利润-35.38百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2436198205","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436198205?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:10","pubTimestamp":1716135006,"startTime":"0","endTime":"0","summary":"3月31日，Arcutis Biotherapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-35.38百万美元；其中营业收入为49.57百万美元，每股基本收益为-0.32美元。从资产负债表来看，Arcutis Biotherapeutics, Inc.总负债2.54亿美元，其中短期债务756000.00美元，资产负债比为1.89，流动比率为0.10。机构评级：截至2024年3月31日，当前有6家机构对Arcutis Biotherapeutics, Inc.目标价做出预测，其中目标均价为18.83美元，其中最低目标价为12.00美元，最高目标价为27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200010138b18620d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200010138b18620d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT"],"gpt_icon":0},{"id":"2435639217","title":"BUZZ--美国股票走势-Nextracker、Arcutis Biotherapeutics、Nu Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2435639217","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435639217?lang=zh_cn&edition=full","pubTime":"2024-05-15 19:49","pubTimestamp":1715773799,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      5月15日 - 美国股指期货周三变动不大，此前将公布重要的消费者物价数据，这些数据将考验近期因货币政策宽松的希望而推动的市场涨势。美东时间 上午 7:37，道指电子盘  上涨0.02%，报39,684点。标普500指数小型股  上涨0.05%，报5272.25点；纳斯达克100指数小型股  上涨0.01%，报18416.5点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0330918003.SGD","HUT","BK4211","BK4516","BK4577","LU0029864427.USD","LU1992135399.USD","BK4566","AMC","HOOD","IE0002270589.USD","RIOT","FCX","BK4112","IE00B19Z3581.USD","DLO","LU0050427557.USD","IE00B894F039.SGD","BK4588","BA","COIN","LU1861558580.USD","BK4023","BK4096","LU0300736492.USD","LU2237438978.USD","LU2272731782.SGD","BK4585","BK4015","NYCB","NXT","HGmain","BK4139","BK4563","LU0456854461.SGD","LU0266512127.USD","LU1023059493.AUD","GME","SCCO","IE00B19Z9Z06.USD","BK4187","BK4195","LU1992135472.HKD","LU2272731600.USD","LU0075056555.USD","ARQT","LU2326559502.SGD","BK4076","BK4551","BK4595"],"gpt_icon":0},{"id":"2435639238","title":"瑞穗银行：维持Arcutis Biotherapeutics(ARQT.US)评级，由买入调整至买入评级, 目标价由17.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435639238","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435639238?lang=zh_cn&edition=full","pubTime":"2024-05-15 19:15","pubTimestamp":1715771744,"startTime":"0","endTime":"0","summary":"瑞穗银行：维持Arcutis Biotherapeutics(ARQT.US)评级，由买入调整至买入评级, 目标价由17.00美元调整至18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515191544876c72b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515191544876c72b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT"],"gpt_icon":0},{"id":"2435681906","title":"BUZZ-制药商 Arcutis 第一季度收入增长，业绩跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2435681906","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435681906?lang=zh_cn&edition=full","pubTime":"2024-05-15 16:56","pubTimestamp":1715763401,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月15日 - ** 制药商Arcutis Biotherapeutics    股价盘前上涨18.3%至9.62美元** 公司第一季度营收4960万美元，去年同期为280万美元** ARQT报告其银屑病和湿疹治疗霜Zoryve的第一季度产品净收入为2160万美元，去年同期为280万美元。** 第一季度净亏损 3540 万美元，去年同期亏损 8010 万美元。** 截至上一交易日收盘，该公司股价已上涨一倍多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","ARQT"],"gpt_icon":0},{"id":"2435526059","title":"Arcutis Biotherapeutics Inc 报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435526059","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435526059?lang=zh_cn&edition=full","pubTime":"2024-05-15 05:22","pubTimestamp":1715721758,"startTime":"0","endTime":"0","summary":"   * Arcutis Biotherapeutics Inc   报告，截至3月底的季度调整后每股亏损32美分，高于去年同期的每股收益1.31美元。五位分析师对该季度的平均预期是每股亏损 73 美分。华尔街预期为每股-91美分至-60美分。* Arcutis Biotherapeutics Inc公布的本季度每股收益为亏损32美分。* Arcutis Biotherapeutics Inc的股价本季度下跌了19.4%，今年迄今为止上涨了147.4%。华尔街对 Arcutis Biotherapeutics Inc 的 12 个月目标价中位数为 17.50 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2435525024","title":"BUZZ-Arcutis 生物治疗公司第一季度收入增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2435525024","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435525024?lang=zh_cn&edition=full","pubTime":"2024-05-15 05:07","pubTimestamp":1715720831,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月14日 - ** 制药商Arcutis Biotherapeutics  盘后股价上涨16.9%至9.50美元** 公司第一季度营收为 4960 万美元，去年同期为 280 万美元** 公司第一季度牛皮癣和湿疹治疗霜 Zoryve 的产品净收入为 2160 万美元，去年同期为 280 万美元。** Arcutis第一季度从预付款和里程碑付款中获得280万美元收入** 公司第一季度净亏损3540万美元，去年同期亏损8010万美元** 股价在过去一年中上涨了一倍多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARQT","BUZZ"],"gpt_icon":0},{"id":"2435783516","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘快速上涨5.26%报8.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435783516","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435783516?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:30","pubTimestamp":1715693452,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时30分，Arcutis Biotherapeutics, Inc.股票出现异动，股价大幅上涨5.26%。截至发稿，该股报8.41美元/股，成交量2.9493万股，换手率0.03%，振幅1.88%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Nutriband Inc C/Wts 、Generation Bio Co.、Allogene Therapeutics, Inc.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为34.53%、6.91%、6.49%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Allogene Therapeutics, Inc.、Precision Biosciences, Inc.，振幅分别为21.54%、12.41%、8.52%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421305287e87cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421305287e87cac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2434892507","title":"Arcutis Biotherapeutics Inc    预计每股亏损 73 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434892507","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434892507?lang=zh_cn&edition=full","pubTime":"2024-05-11 05:35","pubTimestamp":1715376917,"startTime":"0","endTime":"0","summary":"   * Arcutis Biotherapeutics Inc    将于5月14日公布截至2024年3月31日的季度财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州西湖村的公司的营收预计将从去年同期的278万美元增长427.9%，达到1468万美元。* LSEG 分析师对 Arcutis Biotherapeutics Inc 的平均预期是每股亏损 73 美分。* 华尔街对 Arcutis Biotherapeutics Inc 的 12 个月目标价中位数为 17.50 美元，高于其最新收盘价 8.02 美元。5月10日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQT"],"gpt_icon":0},{"id":"2434852563","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘大幅拉升5.24%报8.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434852563","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434852563?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:57","pubTimestamp":1715349479,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时57分，Arcutis Biotherapeutics, Inc.股票出现异动，股价大幅上涨5.24%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，诺瓦瓦克斯医药、Clene Inc C/Wts 30/12/2025 、Celularity Inc C/Wts 16/07/2026 涨幅较大，诺瓦瓦克斯医药、Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为55.80%、29.83%、13.55%，振幅较大的相关个股有Artelo Biosciences Inc C/Wts 20/06/2024 、Celularity Inc C/Wts 16/07/2026 、诺瓦瓦克斯医药，振幅分别为44.63%、32.95%、31.54%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021575987e871e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021575987e871e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcutis.com","stockEarnings":[{"period":"1week","weight":0.0954},{"period":"1month","weight":0.0827},{"period":"3month","weight":-0.0616},{"period":"6month","weight":1.8793},{"period":"1year","weight":0.1164},{"period":"ytd","weight":1.8793}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0344},{"period":"3month","weight":0.0404},{"period":"6month","weight":0.145},{"period":"1year","weight":0.2422},{"period":"ytd","weight":0.145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcutis Biotherapeutics, Inc.前身是根据特拉华州法律于2016年6月成立的，名称为Arcutis，Inc.，后将名称更改为Arcutis Biotherapeutics，Inc.。该公司是一家后期生物制药公司，致力于针对医疗需求未得到满足的皮肤病开发和商业化治疗。他们目前的产品组合包括局部治疗，具有潜在的潜力，可以解决免疫介导的皮肤病和疾病或免疫皮肤病。他们的策略是针对皮肤病学中经过验证的生物学目标识别和开发治疗方法，以提供差异化的临床特征，从而解决现有疗法在目标适应症方面的主要缺点。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.158904},{"month":2,"riseRate":0.8,"avgChangeRate":0.275383},{"month":3,"riseRate":0.4,"avgChangeRate":-0.061223},{"month":4,"riseRate":0.6,"avgChangeRate":0.060261},{"month":5,"riseRate":0.6,"avgChangeRate":-0.10059},{"month":6,"riseRate":0.8,"avgChangeRate":0.067805},{"month":7,"riseRate":0.5,"avgChangeRate":0.005267},{"month":8,"riseRate":0.25,"avgChangeRate":-0.064996},{"month":9,"riseRate":0.5,"avgChangeRate":-0.092979},{"month":10,"riseRate":0,"avgChangeRate":-0.289087},{"month":11,"riseRate":0.25,"avgChangeRate":0.024138},{"month":12,"riseRate":0.75,"avgChangeRate":0.225826}],"exchange":"NASDAQ","name":"Arcutis Biotherapeutics Inc.","nameEN":"Arcutis Biotherapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcutis Biotherapeutics Inc.(ARQT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcutis Biotherapeutics Inc.(ARQT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcutis Biotherapeutics Inc.,ARQT,Arcutis Biotherapeutics Inc.股票,Arcutis Biotherapeutics Inc.股票老虎,Arcutis Biotherapeutics Inc.股票老虎国际,Arcutis Biotherapeutics Inc.行情,Arcutis Biotherapeutics Inc.股票行情,Arcutis Biotherapeutics Inc.股价,Arcutis Biotherapeutics Inc.股市,Arcutis Biotherapeutics Inc.股票价格,Arcutis Biotherapeutics Inc.股票交易,Arcutis Biotherapeutics Inc.股票购买,Arcutis Biotherapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcutis Biotherapeutics Inc.(ARQT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcutis Biotherapeutics Inc.(ARQT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况